Pediatric Interventional Cardiology Market & Competitive Landscape of 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue - ResearchAndMarkets.com

The "Competitive Landscape of Pediatric Interventional Cardiology Market by Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue" has been added to ResearchAndMarkets.com's offering.

The Pediatric Interventional Cardiology Market is projected to reach US$ 4.34 billion by 2033, up from US$ 2.42 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.68% from 2025 to 2033. This growth is driven primarily by the rising prevalence of congenital cardiac disorders in children, including ventricular septal defect (VSD), patent ductus arteriosus (PDA), atrioventricular canal defect, and atrial septal defect (ASD). According to a Cambridge University report, treatable or avoidable heart disease causes the death or disability of nearly 15 million children annually in low- and middle-income countries.

Technological advancements in pediatric interventional cardiology equipment - such as balloons, guidewires, bio-absorbable stents, catheters, vascular closure devices, and atherectomy devices - are further fueling market growth. Patients increasingly prefer minimally invasive procedures due to benefits like reduced infection risk, faster recovery, and minimal scarring.

The United States represents a major market driver, with roughly 40,000 babies born each year with cardiac abnormalities - about 1% of all births. Among these, one in four requires specialized medical care, highlighting the growing demand for pediatric cardiac specialists. Early diagnosis and intervention, supported by improved awareness and diagnostic tools, have led to more children receiving congenital heart defect (CHD) diagnoses and treatments, further propelling the market.

Leading Companies in the Pediatric Interventional Cardiology Market

Abbott Laboratories - Founded in 1888 in the U.S., Abbott reported $42.0B revenue in 2023. The company develops and sells cardiovascular, metabolic, neuromodulation, and structural heart products, among others, via distributors, hospitals, and pharmacies worldwide.

Boston Scientific Corporation - Established in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific generated $16.7B in 2023. It produces devices for interventional cardiology, electrophysiology, vascular surgery, and multiple other medical specialties, selling globally through distributors and direct channels.

Medtronic PLC - Founded in 1949 in Ireland, Medtronic earned $32.4B in 2023. The company designs medical devices for cardiovascular, neurological, and musculoskeletal conditions and distributes products to hospitals, clinics, and healthcare programs worldwide.

Edwards Lifesciences Corporation - Founded in 1958 and headquartered in Irvine, California, Edwards Lifesciences reported $5.4B revenue in 2023. It specializes in structural heart products, surgical valve devices, and hemodynamic monitoring systems, distributing through direct and independent channels globally.

Johnson & Johnson - Established in 1886 in the U.S., J&J generated $88.8B in 2023. The company offers pharmaceutical products for cardiovascular, immunological, neurological, and infectious diseases and medical devices for cardiovascular, orthopedic, neurovascular, and surgical care worldwide.

SWOT Analyses of Key Players

Siemens Healthineers

Strength: Technological leadership and innovation in medical imaging, diagnostics, and AI-powered healthcare solutions.

Opportunity: Expanding digital health and AI integration, including telemedicine, predictive analytics, and cloud-based diagnostic platforms, particularly in emerging markets.

GE HealthCare

Strength: Global reach in over 160 countries and a diverse product portfolio spanning medical imaging, patient monitoring, biomanufacturing, and digital health.

Opportunity: Expansion into emerging markets with scalable and affordable healthcare solutions through strategic partnerships and market-specific innovations.

Cardinal Health Inc.

Strength: Extensive U.S. distribution network, serving over 90% of hospitals and managing 1.5 billion medical products annually.

Opportunity: Growth through strategic acquisitions, such as the $1.12 billion purchase of Integrated Oncology Network, enhancing oncology services and specialized healthcare offerings.

Latest News and Developments:

• In order to expand its pediatric vaccine management platform, Canid raised USD 10 million in SeriesA funding in June 2025. This shows that investors are still confident in pediatric healthcare technology solutions that improve patient outcomes and expedite clinical procedures.
• Abbott's Tendyne transcatheter mitral valve replacement system, which is the first of its type to replace mitral valves without open heart surgery and will especially help patients with severe mitral annular calcification, was approved by the FDA in April 2025.
• In January 2025, Boston Scientific successfully acquired Bolt Medical for a maximum price of USD 664 million, increasing its capacity to treat complex calcified artery disease in both adult and pediatric patients using intravascular lithotripsy technology.
• December 2024: To provide specialist care for children with cardiac disorders, DPU Super Speciality Hospital in Pimpri, Pune, opened a 10-bed Pediatric Cardiac ICU. With its state-of-the-art medical equipment and knowledgeable staff, the facility guarantees all-encompassing treatment and the best possible results. Bajaj Finserv made this program possible via a CSR contribution.

Key Attributes

Companies Featured:

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc.
• Siemens AG (Siemens Healthineers)
• General Electric (GE Healthcare)
• Cardinal Health Inc.
• Edwards Lifesciences
• Terumo Corporation
• NuMED Inc.
• Johnson & Johnson
• Cordis Corporation
• Merit Medical Systems
• MicroPort Scientific Corporation
• B. Braun Melsungen AG
• Cook Medical

For more information about this report visit https://www.researchandmarkets.com/r/249wgw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251111922672/en/